Trial Profile

Phase I trial of XOMA 358 in healthy volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ersodetug (Primary)
Indications Hyperinsulinaemia; Hypoglycaemia; Insulinoma
Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
Sponsors XOMA

Most Recent Events

15 Sep 2016 According to XOMA media release, updates from this and other three studies of XOMA-358 were presented in a webcast on 15 Sep 2016.
11 Mar 2015 Status changed from recruiting to completed, according to a XOMA Corporation media release.
08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com